PMC:7650537 / 14641-15126 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T104","span":{"begin":338,"end":341},"obj":"Body_part"}],"attributes":[{"id":"A104","pred":"fma_id","subj":"T104","obj":"http://purl.org/sig/ont/fma/fma62872"}],"text":"Specificity was calculated using 100 archived samples that should not contain SARS-CoV-2 antibodies. A total of ten sera were reactive in one or more assays. None contained SARS-CoV-2 neutralizing antibodies (Figure 2 and Figure S1). The residual 90 stored samples were not tested in the PRNT, as they were found to be free of SARS-CoV-2 IgG/total antibodies in all eight assays. Thus, assay specificities ranged from 96.0% to 100%, and accuracies varied from 93.7% to 99.2% (Table 1)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T72","span":{"begin":78,"end":86},"obj":"Disease"},{"id":"T73","span":{"begin":173,"end":181},"obj":"Disease"},{"id":"T74","span":{"begin":327,"end":335},"obj":"Disease"}],"attributes":[{"id":"A72","pred":"mondo_id","subj":"T72","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A73","pred":"mondo_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A74","pred":"mondo_id","subj":"T74","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Specificity was calculated using 100 archived samples that should not contain SARS-CoV-2 antibodies. A total of ten sera were reactive in one or more assays. None contained SARS-CoV-2 neutralizing antibodies (Figure 2 and Figure S1). The residual 90 stored samples were not tested in the PRNT, as they were found to be free of SARS-CoV-2 IgG/total antibodies in all eight assays. Thus, assay specificities ranged from 96.0% to 100%, and accuracies varied from 93.7% to 99.2% (Table 1)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T135","span":{"begin":101,"end":102},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T136","span":{"begin":112,"end":115},"obj":"http://purl.obolibrary.org/obo/CLO_0050884"},{"id":"T137","span":{"begin":229,"end":231},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"},{"id":"T138","span":{"begin":274,"end":280},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Specificity was calculated using 100 archived samples that should not contain SARS-CoV-2 antibodies. A total of ten sera were reactive in one or more assays. None contained SARS-CoV-2 neutralizing antibodies (Figure 2 and Figure S1). The residual 90 stored samples were not tested in the PRNT, as they were found to be free of SARS-CoV-2 IgG/total antibodies in all eight assays. Thus, assay specificities ranged from 96.0% to 100%, and accuracies varied from 93.7% to 99.2% (Table 1)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T114","span":{"begin":0,"end":100},"obj":"Sentence"},{"id":"T115","span":{"begin":101,"end":157},"obj":"Sentence"},{"id":"T116","span":{"begin":158,"end":233},"obj":"Sentence"},{"id":"T117","span":{"begin":234,"end":379},"obj":"Sentence"},{"id":"T118","span":{"begin":380,"end":485},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Specificity was calculated using 100 archived samples that should not contain SARS-CoV-2 antibodies. A total of ten sera were reactive in one or more assays. None contained SARS-CoV-2 neutralizing antibodies (Figure 2 and Figure S1). The residual 90 stored samples were not tested in the PRNT, as they were found to be free of SARS-CoV-2 IgG/total antibodies in all eight assays. Thus, assay specificities ranged from 96.0% to 100%, and accuracies varied from 93.7% to 99.2% (Table 1)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"265","span":{"begin":78,"end":88},"obj":"Species"},{"id":"266","span":{"begin":173,"end":183},"obj":"Species"},{"id":"267","span":{"begin":327,"end":337},"obj":"Species"}],"attributes":[{"id":"A265","pred":"tao:has_database_id","subj":"265","obj":"Tax:2697049"},{"id":"A266","pred":"tao:has_database_id","subj":"266","obj":"Tax:2697049"},{"id":"A267","pred":"tao:has_database_id","subj":"267","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Specificity was calculated using 100 archived samples that should not contain SARS-CoV-2 antibodies. A total of ten sera were reactive in one or more assays. None contained SARS-CoV-2 neutralizing antibodies (Figure 2 and Figure S1). The residual 90 stored samples were not tested in the PRNT, as they were found to be free of SARS-CoV-2 IgG/total antibodies in all eight assays. Thus, assay specificities ranged from 96.0% to 100%, and accuracies varied from 93.7% to 99.2% (Table 1)."}